冠狀動脈成形術市場規模、佔有率和成長分析：依手術類型、器械類型、最終用戶和地區分類－2026-2033年產業預測

2024年全球冠狀動脈血管成形術市場價值為8.979億美元，預計將從2025年的9.6794億美元成長到2033年的17.6521億美元。預測期（2026-2033年）的複合年成長率預計為7.8%。

全球冠狀動脈成形術市場深受缺血性心臟疾病盛行率的上升主要歸因於人口老化以及糖尿病、高血壓和肥胖等生活方式因素。這種微創手術包括球囊擴張和支架植入，在降低死亡率、縮短住院時間和加速患者復原方面發揮至關重要的作用。技術進步，例如從傳統球囊到藥物釋放型支架的演變以及影像技術的改進，顯著改善了患者的治療效果。此外，人工智慧在臨床環境中的應用增強了診斷和手術規劃，從而實現了更精準的介入治療。隨著新興市場心血管篩檢的普及以及成熟地區橈動脈入路技術的日益廣泛應用，市場需求環境正在改善，這有利於器械製造商、醫療服務提供者和患者。

全球冠狀動脈成形術市場促進因素

心血管疾病發生率的上升導致需要介入治療的患者數量顯著增加，從而推動了對冠狀動脈成形術及相關器械的需求。隨著缺血性疾病患者數量的增加，能夠縮短恢復時間並精準標靶化病變部位的微創經皮治療方法越來越受到青睞。這一趨勢促使醫療機構擴充導管檢查室資源和設備庫存。此外，醫護人員和患者對這些治療方法益處的認知不斷提高，進一步提升了其應用率，從而促進了市場持續成長，並增強了對這些重要手術的需求。

全球冠狀動脈成形術市場的限制因素

全球冠狀動脈成形術市場面臨許多限制因素，阻礙了其廣泛應用和普及，主要原因在於手術及先進器械的高成本。不完善的報銷政策和緊張的機構預算加劇了這些挑戰，導致醫療機構在更新和擴展服務方面更加謹慎。導管檢查室所需的大量資本投入，以及專用耗材的持續成本，進一步複雜化了這個問題，尤其是在資源匱乏的環境中。此外，病人對經濟負擔的擔憂導致自付費用較高時手術率下降，使得相關人員優先考慮成本控制而非快速採用創新技術。

全球冠狀動脈成形術市場趨勢

在全球冠狀動脈成形術市場，將影像和生理評估整合到手術流程中是一個顯著的趨勢。這種整合增強了可視化效果，並能更精確地表徵病變，使醫療專業人員能夠做出明智的決策，從而根據患者的個別需求制定干涉措施。隨著供應商開發出能夠整合影像和血流數據的互通平台，多重模式分析的重要性也透過專門的培訓計畫得到了進一步強調。這種無縫整合有助於精準治療，推動臨床實踐中實證醫學證據的產生，並最終增強採用先進血管成形術解決方案的合理性。預計這將改善患者預後，並提高醫療機構對該技術的接受度。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢

全球冠狀動脈成形術市場規模：依手術類型和複合年成長率分類（2026-2033 年）

• 經皮冠狀動脈介入治療
  • 球囊血管成形術
  • 支架置入術
• 冠狀動脈繞道術

全球冠狀動脈成形術市場規模：依器械類型和複合年成長率分類（2026-2033 年）

• 支架
  • 藥物釋放型支架
  • 裸金屬支架
• 血管成形術用氣球
  • 標準氣球
  • 球囊導管

全球冠狀動脈成形術市場規模：依最終用戶和複合年成長率分類（2026-2033 年）

• 醫院
• 心臟診所
• 其他

全球冠狀動脈成形術市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• Abbott Laboratories
• Boston Scientific
• Medtronic
• Johnson & Johnson
• Terumo Corporation
• B. Braun Melsungen AG
• Cardiovascular Systems, Inc.
• Cardinal Health
• Cook Medical
• Siemens Healthineers
• Philips Healthcare
• Anthos Therapeutics
• Saranas, Inc.
• Biotronik
• Edwards Lifesciences
• Gore Medical
• AngioDynamics
• Asahi Intecc
• Medtronic's Miniature Coronary Intervention
• Meril Life Sciences

結論與建議

Global Coronary Angioplasty Market size was valued at USD 897.9 Million in 2024 and is poised to grow from USD 967.94 Million in 2025 to USD 1765.21 Million by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The global coronary angioplasty market is significantly influenced by the increasing prevalence of ischemic heart disease, primarily driven by aging populations and lifestyle factors such as diabetes, hypertension, and obesity. This minimally invasive procedure, which involves balloon dilation and stent placement, plays a crucial role in lowering mortality, reducing hospital stays, and facilitating faster patient recovery. Technological advancements, including the evolution from conventional balloons to drug-eluting stents and enhanced imaging techniques, have considerably improved patient outcomes. Moreover, the integration of AI in clinical settings enhances diagnosis and procedural planning, enabling more precise interventions. As emerging markets witness expanded cardiovascular screenings and established regions embrace radial access methods, a favorable demand landscape develops, benefiting device manufacturers, healthcare providers, and patients alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Coronary Angioplasty market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Coronary Angioplasty Market Segments Analysis

Global coronary angioplasty market is segmented by procedure type, device type, end user and region. Based on procedure type, the market is segmented into Percutaneous Coronary and Coronary Artery Bypass. Based on device type, the market is segmented into Stents and Angioplasty Balloons. Based on end user, the market is segmented into Hospitals, Cardiac Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Coronary Angioplasty Market

The rising incidence of cardiovascular diseases significantly amplifies the number of patients in need of interventional treatments, subsequently driving the demand for coronary angioplasty procedures and associated devices. As physicians encounter more patients with ischemic conditions, there is an increasing preference for minimally invasive percutaneous techniques, which facilitate quicker recovery times and precise lesion targeting. This trend encourages healthcare facilities to enhance their catheterization lab resources and device inventories. Additionally, heightened awareness among both healthcare providers and patients regarding the advantages of these treatments further boosts the adoption rates, contributing to the continuous growth of the market and reinforcing the demand for these essential procedures.

Restraints in the Global Coronary Angioplasty Market

The global coronary angioplasty market faces several constraints mainly due to the high costs linked to procedures and advanced devices, which hinder widespread access and adoption. Insufficient reimbursement policies and tight institutional budgets exacerbate these challenges, as healthcare providers become more cautious in upgrading or expanding their services. The substantial capital investment required for catheterization labs, coupled with ongoing costs for specialized consumables, further complicates matters, especially in resource-limited environments. Additionally, concerns about patient affordability lead to reduced uptake of procedures when out-of-pocket costs are burdensome, ultimately prompting stakeholders to focus on cost containment rather than the swift acquisition of innovative technologies.

Market Trends of the Global Coronary Angioplasty Market

The Global Coronary Angioplasty market is experiencing a significant trend towards the integration of imaging and physiological assessments within intraprocedural workflows. This convergence allows for enhanced visualization and more precise lesion characterization, empowering practitioners to make informed decisions that tailor interventions to individual patient needs. As vendors develop interoperable platforms that merge imaging and flow data, the emphasis on multimodality interpretation is reinforced through specialized training programs. This seamless integration fosters precision interventions, drives evidence generation in real-world scenarios, and ultimately strengthens the case for adopting advanced angioplasty solutions, leading to improved patient outcomes and increased institutional acceptance.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Coronary Angioplasty Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Percutaneous Coronary
  • Balloon Angioplasty
  • Stent Placement
• Coronary Artery Bypass

Global Coronary Angioplasty Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Stents
  • Drug-Eluting Stents
  • Bare-Metal Stents
• Angioplasty Balloons
  • Standard Balloons
  • Scoring Balloons

Global Coronary Angioplasty Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Clinics
• Others

Global Coronary Angioplasty Market Size & CAGR (2026-2033)

• North America (Procedure Type, Device Type, End User)
  • US
  • Canada
• Europe (Procedure Type, Device Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Procedure Type, Device Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Procedure Type, Device Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Procedure Type, Device Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiovascular Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anthos Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saranas, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gore Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic's Miniature Coronary Intervention
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations